1 / 8

Lucentis (Microvascular Complications of Diabetes) Market An

The entire market for microvascular complications of diabetes (MCD)

fareeqrahal
Télécharger la présentation

Lucentis (Microvascular Complications of Diabetes) Market An

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Lucentis (Microvascular Complications of Diabetes) – Forecast and Market Analysis to 2022byGlobalData Explore all reports for “ Diabetes Therapeutics” market @ http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics/diabetes-therapeutics . © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

  2. Lucentis (Microvascular Complications of Diabetes) – Forecast and Market Analysis to 2022 The entire market for microvascular complications of diabetes (MCD) diabetic nephropathy, retinopathy, and neuropathy is facing an extremely high level of unmet need across the 7MM (US, 5EU and Japan). Despite its enormous potential, the MCD market is facing the major global barrier in the sparsely populated pipeline. The diabetic retinopathy segment of the market has recently seen rapid uptake of novel anti-VEGF therapies and is experiencing a strong growth. On the other hand, the diabetic neuropathy and nephropathy segments face the barrier in and increasing number of generic competitors. Lucentis (ranibizumab) is a humanized fragment antigen-binding(Fab) fragment of an immunoglobulin G1 (IgG1) monoclonal antibody (mAb) that specifically binds to all isoforms of vascular endothelial growth factor (VEGF)-A, thereby preventing the binding of VEGF-A to its vascular endothelial growth factor receptor (VEGFR)-1 and (VEGFR-2) (Bandello et al., 2012). Request sample copy of this report @ http://www.rnrmarketresearch.com/contacts/request-sample?rname=147159 . © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

  3. Lucentis (Microvascular Complications of Diabetes) – Forecast and Market Analysis to 2022 Scope Overview of MCD, including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape. Detailed information on Lucentisincluding product description, safety and efficacy profiles as well as a SWOT analysis. Sales forecast for Lucentis for the top seven countries from 2012 to 2022. Sales information covered for the US, France, Germany, Italy, Spain, the UK and Japan. Complete report available @ http://www.rnrmarketresearch.com/lucentis-microvascular-complications-of-diabetes-forecast-and-market-analysis-to-2022-market-report.html . © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

  4. Lucentis (Microvascular Complications of Diabetes) – Forecast and Market Analysis to 2022 Reasons to buy Understand and capitalize by identifying products that are most likely to ensure a robust return Stay ahead of the competition by understanding the changing competitive landscape for MCD Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential Make more informed business decisions from insightful and in-depth analysis of Lucentis performance Obtain sales forecast for Lucentis from 2012-2022 in top seven countries (the US, France, Germany, Italy, Spain, the UK and Japan) Request sample copy of this report @ http://www.rnrmarketresearch.com/contacts/request-sample?rname=147159 . © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

  5. Lucentis (Microvascular Complications of Diabetes) – Forecast and Market Analysis to 2022 Table Of Contents 1 Table of Contents1 Table of Contents 61.1 List of Tables 81.2 List of Figures 8 2 Introduction 92.1 Catalyst 92.2 Related Reports 10 3 Disease Overview 123.1 Etiology and Pathophysiology 143.1.1 Diabetic Nephropathy 143.1.2 Diabetic Retinopathy 163.1.3 Diabetic Neuropathy 173.2 Prognosis 183.3 Quality of Life 193.4 Symptoms 20 Request sample copy of this report @ http://www.rnrmarketresearch.com/contacts/request-sample?rname=147159 . © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

  6. Lucentis (Microvascular Complications of Diabetes) – Forecast and Market Analysis to 2022 4 Disease Management 214.1 Treatment Overview 214.1.1 Diagnosis and Referrals 214.1.2 Screening 234.1.3 Treatment Guidelines 24 5 Competitive Assessment 325.1 Overview 325.2 Strategic Competitor Assessment 33 6 Lucentis (ranibizumab) 376.1 Overview 376.2 Efficacy 396.3 Safety 406.4 SWOT Analysis 416.5 Forecast 41 Request sample copy of this report @ http://www.rnrmarketresearch.com/contacts/request-sample?rname=147159 . © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

  7. Lucentis (Microvascular Complications of Diabetes) – Forecast and Market Analysis to 2022 7 Appendix 437.1 Bibliography 437.2 Abbreviations 487.3 Methodology 517.4 Forecasting Methodology 517.4.1 Diagnosed Patients 517.4.2 Percent Drug-Treated Patients 527.4.3 General Pricing Assumptions 527.4.4 Individual Drug Assumptions 537.4.5 Generic Erosion 537.5 Physicians and Specialists Included in this Study 547.6 About the Authors 567.6.1 Analyst II - CVMD 567.6.2 Therapy Director - CVMD and Infectious Disease 567.6.3 Global Head of Healthcare 577.7 About GlobalData 587.8 Disclaimer 58 Request sample copy of this report @ http://www.rnrmarketresearch.com/contacts/request-sample?rname=147159 . © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

  8. China nuclear power generation industry, 2014 For more details contact Mr. PriyankTiwari:sales@rnrmarketresearch.com/ +18883915441 RnR Market Research RnRMarketResearch.com, an online repository of market  research reports, offers in-depth analysis of over 5000 market segments. RnR  Market Research library has syndicated reports by leading market research  publishers across the globe. © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

More Related